$ARCT Arcturus Therapeutics Reversal Targets post 50% decline
Potential reversal opportunity after a harsh selloff
as a result of multiple downgrades post vaccine update.
Investors looking past the other pipeline projects.
Weekly 50ma held
Point of Control (POC) held as support.
Buyers and traders jumped on the opportunity yesterday. (AS did we)
Looking for potential break above the 200ma today, which could ignite a
nice rally.
$54.80 Pivot pint target
$60.00 100ma target
$63.00 previous channel Trendline.
High risk stock so care needed and SL in place.
ARCT trade ideas
BREAKOUT CUP WITH HANDLE, HIGH VOLUM DAILY, BUY WEEKLY ARCT 80$Covid Vaccine Could Be a Drug Industry Game Changer
The value of vaccines has never, ever been clearer. With Covid-19 resurgent globally, Pfizer and BioNTechreported Monday that their vaccine looks as if it can cut infection rates by over 90%. Hearts and stocks leapt, especially stocks in pandemic-penned sectors, such as retail, restaurants, and travel. Wednesday, Moderna said it would soon have results on its vaccine trial.
“This has such far-reaching consequences in everybody’s lives,” says Bill Gruber, Pfizer’s senior vice president of clinical research and development....
1% CAPITAL
ARCT ShortARCT has a multiple top, and is currently at resistance. Even if you want to trade it with a mean-reversion strategy, you could still wait until it goes down to a support level. I highlighted three support levels. If you are a momentum trader, you can wait until it goes down to support, and then short it, right before it breaks below. Thanks.
Rejection Formation - 1 hr interval - ARCTHello Everyone,
The stock (ARCT) appears to have been oversold within the last week few weeks of March. Considering an imminent rejection may take place. Be cautious of the value (either an immediate rejection) or a pull up towards (7.15-7.30) and then bearish momentum.
Not Investment Advice. For Educational and Analytical Purposes Only. (Be Aware and Stick To Your Trading Plan)***
-LionGate
ARCT showing possible signs of a breakout in the near future.ARCT has been trading sideways for the better part of two months. In addition, it has recently exhibited a large spike in buy-back volume. This comes after a news report that states that Arcturus Therapeutics announced a “broad strategic collaboration to advance next generation of lipid-mediated mRNA therapeutics”. Moreover, the RSI has shown a drastic spike in strength over the last couple of days. This highlights a potential breakout formation. Marked in blue is an identified psychological resistance line, the next dollar point. Furthermore, the MACD shows the opening of a buyback period. This stock shows a very promising bullish movement. Although yesterday’s trading day closed beneath the 13EMA, it has closed above it. I could see the stock riding the 13EMA up from here on out and I would take a half or quarter position until the stock shows more promise of a verified breakout. Bare in mind that this is a smaller company as there are only 19 employees and an estimated 3 shareholders.